Dexamethasone intravitreous implantversusbevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison

A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group

(2012) Tina Aggermann et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intravitreal Bevacizumab in Central Retinal Vein Occlusion: 18-month Results of a Prospective Clinical Trial

(2011) Peep V. Algvere et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Results of bevacizumab as the primary treatment for retinal vein occlusions

(2010) M. S. Figueroa et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion

(2010) Julia A. Haller et al.   OPHTHALMOLOGY

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion

(2009)   ARCHIVES OF OPHTHALMOLOGY

Intravitreal bevacizumab (Avastin(R)) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

(2008) F Prager et al.   BRITISH JOURNAL OF OPHTHALMOLOGY